In Phase A, participants will obtain distinctive doses and schedules of oral ABBV-744 tablet to discover safe dosing regimen. Further members will probably be enrolled for the discovered monotherapy dosign regimen. In Segment B, individuals will obtain oral ruxolitinib and ABBV-744 are going to be offered as "add-on" therapy. In https://carle433sbm6.onzeblog.com/profile